跳轉至內容
Merck
全部照片(1)

重要文件

T3809

Sigma-Aldrich

TRI试剂®

BD, For processing whole blood, plasma, or serum.

同義詞:

TRI试剂® RNA 分离试剂

登入查看組織和合約定價


About This Item

MDL號碼:
分類程式碼代碼:
12352200
NACRES:
NA.52
暫時無法取得訂價和供貨情況

品質等級

用途

0.75 mL sufficient for 0.25 mL blood derivatives

尋找類似的產品? 前往 產品比較指南

一般說明

TRI reagent®是苯酚和异硫氰酸胍的单相溶液。[1]
TRI试剂BD是一种可用于从血清、血浆或全血中进行RNA、DNA和蛋白同时分离的快速便捷型试剂。便捷的一步液相分离可实现RNA、DNA和蛋白的同时分离。该过程是对由Chomczynski和Sacchi所报道的一步法方法的升级,并可实现对血液衍生物的快速而有效处理。

TRI试剂BD非常适合处理大小体积的样品,且可同时提取多份样品。TRI试剂BD是一种硫氰酸胍和苯酚的单相混合溶液。用它对血液衍生物进行裂解并加入氯仿或1-溴-3-氯丙烷时,混合液会分离为3相:含有RNA的水相、含有DNA的中间相以及含有蛋白的有机相。随后每种组分可在相分离后得到分离。0.75 ml的TRI试剂BD可处理0.25 ml的血液衍生物。

这是分离总RNA最为有效的方法之一,以新鲜细胞起始仅需1小时便能完成。该过程可超高效分离0.1至15 kb的各种RNA分子。得到的RNA可保持完整,并不含或仅含极少量DNA或蛋白。

應用

TRI试剂®已用于分离RNA。[2][3]
TRI试剂是对由Chomczynski开发的一步法总RNA分离试剂进行改良的一种版本。基于该试剂的RNA分离方法已被广泛用于和验证用于RNA应用。它是对来自人、动物、植物、酵母、细菌和病毒来源样本进行总RNA或RNA、DNA和蛋白同时分离的一种理想的快速、经济和高效的方法。
产生的RNA可用于Northern blot、mRNA分离、体外翻译、RNase保护检测、克隆及PCR。

特點和優勢

  • 可轻松扩展的RNA分离
  • 可适用于多种来源:人、植物、酵母、细菌或病毒
  • 相对于传统的硫氰酸胍/氯化铯具有更高的产量

法律資訊

TRI Reagent is a registered trademark of Molecular Research Center, Inc.

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Muta. 2 - Skin Corr. 1B - STOT RE 2

標靶器官

Nervous system,Kidney,Liver,Skin

安全危害

儲存類別代碼

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

水污染物質分類(WGK)

WGK 3

閃點(°F)

174.2 °F - closed cup

閃點(°C)

79 °C - closed cup


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

John-Edwin Thomson et al.
Pancreas, 48(1), 107-112 (2018-11-20)
Interleukin-21 (IL-21) is a cytokine associated with tissue inflammation, autoimmune and infectious diseases. Organ dysfunction and death can occur in patients with acute pancreatitis (AP) in two distinct clinical phases. Initially, a systemic inflammatory response syndrome may be followed by
Circulating ribonucleic acids and metabolic stress parameters may reflect progression of autoimmune or inflammatory conditions in juvenile type 1 diabetes.
Kocic G
TheScientificWorldJournal, 11, 1496-1508 (2011)
Heiner Kuhl et al.
Molecular biology and evolution, 38(1), 108-127 (2020-08-12)
Presumably, due to a rapid early diversification, major parts of the higher-level phylogeny of birds are still resolved controversially in different analyses or are considered unresolvable. To address this problem, we produced an avian tree of life, which includes molecular
A novel CLCN5 mutation in a Chinese boy with Dent's disease.
Ji LN
World Journal of Pediatrics : WJP, 10(3), 275-277 (2014)
Purification of RNA using TRIzol (TRI reagent)
Rio D, et al.
Cold Spring Harbor Protocols, 2010(6), pdb-prot5439 (2010)

文章

Simple DNA/RNA purification methods aid genome analysis from various sources, enhancing research efficiency.

簡單的 DNA/RNA 純化方法有助於從各種來源進行基因組分析,提高研究效率。

Questions

  1. When using Tri Reagent BD, do we need to add EDTA to blood samples to prevent coagulation?

    1 answer
    1. The Product Information available under More Documents or at this link (https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/436/845/t3809bul.pdf) provides the following instructions:

      I. Sample Preparation:

      1A. Serum: Add 0.25 ml of serum to 0.75 ml of TRI Reagent BD. Close the tube and shake the solution by hand or vortex, ensuring that mixing is thorough.

      1B. Whole Blood or Plasma: Add 0.2 ml of whole blood or plasma to 0.75 ml of TRI Reagent BD supplemented with 20 ml of 5 N acetic acid per 0.2 ml of whole blood or plasma. Close the tube and shake the solution by hand or vortex, ensuring that mixing is thorough.

      It is possible to use whole blood (blood that has been allowed to clot), serum, or plasma. Blood that has clotted would be referred to as a clot plus serum or simply as clotted blood. If you are freshly drawing the blood and adding immediately to the Tri Reagent, an anticoagulant would not be required. For serum samples, the blood is simply allowed to clot. The clot is spun down and serum is collected above the clot. If plasma is used, this indicates the blood is first drawn into either a tube containing an anticoagulant or drawn with a syringe and then transferred to a tube containing an anticoagulant. The blood is then centrifuged and the plasma is removed before adding to the Tri Reagent. We would not recommend allowing the blood to clot and then trying to add the clotted blood to the Tri Reagent.

      Helpful?

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務